Taipei, Taiwan

Jaulang Hwang

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2002-2019

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jaulang Hwang: A Pioneering Inventor in Vaccine Development

Introduction

Jaulang Hwang, based in Taipei, Taiwan, is a distinguished inventor with a significant impact in the field of vaccine composition and treatment methodologies. With a total of five patents to his name, Hwang's work primarily focuses on innovative solutions for inflammation and related lung injuries.

Latest Patents

Among his latest patents, Hwang developed a groundbreaking vaccine composition aimed at alleviating inflammation and preventing lung injuries, particularly those induced by hyperoxia. This invention showcases the efficacy of Tn immunization in boosting serum anti-Tn antibody titers while simultaneously reducing lavaged protein, cytokines, and lung injury scores. The findings suggest that this approach improves lung injury outcomes while decreasing NF-κB activity, thereby enhancing the therapeutic potential against hyperoxia-induced desolation and periodontitis.

Additionally, Hwang's patent concerning the CETP antigenic peptide and its fusion protein provides a notable innovation in cardiovascular health. This patent offers a solution by targeting the extracellular form of CETP, aimed at reducing LDL levels and increasing HDL. The development of a CETP vaccine addresses the challenge of low immunogenicity, paving the way for long-term inhibition of CETP activity, which could be instrumental in preventing or treating various LDL derivative-related diseases.

Career Highlights

Jaulang Hwang’s professional journey includes pivotal roles at esteemed research institutions such as Academia Sinica and Taipei Medical University. His contributions in these environments have significantly advanced the understanding and application of his innovative patents.

Collaborations

Hwang has collaborated with notable individuals in his field, including Chia-Tse Hsu and Chun-Jen Ting. These collaborations have further enriched his research endeavors, leading to impactful advancements in vaccine technology.

Conclusion

In summary, Jaulang Hwang stands out as a prominent inventor whose contributions are crucial in the realms of vaccine development and treatment of lung injuries. His latest patents demonstrate not only his innovative spirit but also his commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…